Oramed Pharmaceuticals Inc.

Regulatory Filings • Aug 11, 2022

_________ false

����� ����������� ����	2 379
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	14166
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	11/08/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-101686	Time of broadcast: 00:09 00:09

---

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onForm 10-Q for quarter ending June 30, 2022

Q2_2022_Form_10-Q_-_August_10_2022_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 02/08/2022
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: DEROVAN NETANEL MOSHE Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414904 Telephone: 02-5660001 Facsimile: E-mail: netanel@oramed.com 1
USA